Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China Pharma Holdings (CPHI) Free Cash Flow (2016 - 2025)

China Pharma Holdings filings provide 16 years of Free Cash Flow readings, the most recent being $73275.0 for Q4 2025.

  • On a quarterly basis, Free Cash Flow fell 73.76% to $73275.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $10676.0, a 102.56% increase, with the full-year FY2025 number at $10676.0, up 102.4% from a year prior.
  • Free Cash Flow hit $73275.0 in Q4 2025 for China Pharma Holdings, up from -$237598.0 in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of $939831.0 in Q3 2023 to a low of -$1.4 million in Q1 2023.
  • Median Free Cash Flow over the past 5 years was -$95525.0 (2024), compared with a mean of -$130064.8.
  • Biggest five-year swings in Free Cash Flow: skyrocketed 2911.59% in 2023 and later crashed 529.7% in 2025.
  • China Pharma Holdings' Free Cash Flow stood at -$205168.0 in 2021, then soared by 398.22% to $611862.0 in 2022, then plummeted by 104.39% to -$26850.0 in 2023, then soared by 1139.96% to $279228.0 in 2024, then crashed by 73.76% to $73275.0 in 2025.
  • The last three reported values for Free Cash Flow were $73275.0 (Q4 2025), -$237598.0 (Q3 2025), and $293323.0 (Q2 2025) per Business Quant data.